雲頂新耀:加速腎病領域創新 邁向全球生物製藥領先地位

香港, 2024年12月11日 - (亞太商訊 via SeaPRwire.com) - 據《南華早報》報導,雲頂新耀(HKEX 1952.HK)正加速實現其成為亞太地區領先生物製藥企業的願景。公司憑藉強大的研發實力與卓越的商業化能力,在持續推動業務發展的同時,不斷深化在全球生物製藥領域的佈局。近期,雲頂新耀在核心商業化產品和突破性研究方面取得了一系列重要的里程碑式進展,充分體現了其在為亞洲乃至全球患者提供創新治療解決方案方面的堅定承諾與卓越能力。這些成就不僅鞏固了公司在行業中的領先地位,也進一步彰顯了其致力於滿足未被滿足醫療需求的長期戰略願景。EVER001:腎病創新領域的突破2024年12月4日,雲頂新耀宣佈其自主研發且擁有全球權益的新一代共價可逆布魯頓酪氨酸激酶(BTK)抑制劑EVER001,在1b/2a期臨床試驗階段性資料中取得積極結果。本次試驗聚焦原發性膜性腎病(pMN),是成人原發性腎病綜合征的主要原因,存在未被滿足的醫療需求。近年來,中國pMN的發病率持續上升,成為繼IgA腎病(IgAN)後的第二大腎病綜合征常見的病理類型。目前,中國約200萬原發性膜性腎病患者,而在美國約有8萬-10萬患者,歐洲約8萬患者,日本約4萬患者,疾病負擔在全球範圍內日益加重,且目前全球沒有獲批此適應症的藥物。不同于傳統的共價不可逆BTK抑制劑,EVER001採用獨特的共價可逆機制,結合其強大的靶點結合力與良好的安全性特徵,避免持續抑制帶來的毒副作用。試驗結果顯示,抗-PLA2R自身抗體水準在資料截止日期時已達到接近100%的下降,而早在低劑量組的24周和高劑量組的12周,抗-PLA2R自身抗體下降已超過90%。此外,在已完成36周治療的低劑量組患者中,81.8%的患者實現臨床緩解,高劑量組中已完成24周治療的患者已有85.7%實現臨床緩解。除低劑量組的1例患者外,其他所有完成36周治療的低劑量組患者,以及所有經24周治療的高劑量組患者分別在36周和24周都實現了免疫學完全緩解。EVER001作為一款潛在的同類最佳產品,該結果不僅顯示了EVER001在pMN治療中的高選擇性、優異的藥代動力學特徵、良好的安全性特徵以及強大的靶點結合力,還凸顯了其在其他自身免疫性腎病,如狼瘡性腎炎(LN)、IgA腎病、微小病變病(MCD)和局部節段性腎小球硬化(FSGS)中的廣闊適應症前景。憑藉廣泛的適應症前景、日益增加的疾病發病率以及全球範圍內的開發權益,EVER001成為具有顯著商業價值的「藍海」資產。近年來,腎病治療領域已成為醫藥創新與資本投資的熱點,吸引了眾多跨國製藥巨頭的目光。以2023年為例,Vertex Pharmaceuticals斥資49億美元收購了Alpine Immune Sciences,以獲取其針對腎臟自身免疫性疾病的先進療法。同年,諾華(Novartis)以35億美元收購了Chinook Therapeutics,從而獲得兩項處於後期開發階段的罕見腎病治療藥物。這些交易不僅凸顯了全球醫藥行業對腎病領域的重視,也進一步驗證了該領域創新治療方案的巨大潛力和市場價值。「雙輪驅動」戰略推動商業化成功雲頂新耀通過核心產品耐賦康(R)進一步鞏固了其在腎病治療領域的領導地位。耐賦康(R)是全球首個獲得FDA批准的IgA腎病(IgAN)對因治療藥物,同時也是中國首個獲得IgA腎病適應症的對因治療藥物。該藥物已成功納入2024年國家醫保藥品目錄,這一里程碑不僅顯著提升了患者可及性,還將大幅推動市場滲透率,其相關政策將於2025年1月1日正式實施。自2024年5月在中國大陸商業化上市以來,僅一個月耐賦康(R)銷售額即突破人民幣1.673億元。此外,該藥物還在中國澳門、中國香港、中國台灣、韓國及新加坡獲批,進一步彰顯了雲頂新耀在全球腎病領域的專業實力與市場影響力。雲頂新耀的多元化產品組合還包括氟環素類抗菌藥物依嘉(R)與自身免疫疾病治療藥物伊曲莫德(VELSIPITY(R))。依嘉(R)作為全球首個氟環素類抗菌藥物,在國家衛生健康委抗菌藥物臨床應用與耐藥評價專家委員會發起並主辦的「依拉環素臨床應用綜合評價项目」中表現卓越,臨床療效分析顯示,依拉環素治療3天時的整體有效率為91.1%,治療結束時整體有效率為90.1%。截至2024年上半年,依嘉(R)累計銷售額已達到2.33億元,充分體現了市場對其的高度認可和接受度。在自身免疫疾病領域,伊曲莫德(VELSIPITY(R))的商業化進程取得重要進展。該產品已在中國澳門和新加坡獲批上市,並通過「港澳藥械通」政策率先進入粵港澳大灣區,成為雲頂新耀第三款商業化產品。近期,伊曲莫德的新藥上市許可申請已在中國香港獲正式受理,公司計畫於今年底向中國大陸遞交申請,進一步釋放其市場潛力。在研發領域,經過臨床驗證的mRNA技術平台是公司自主研發的核心部分,公司將自主研發重點轉向擁有全部智慧財產權和全球權益的mRNA腫瘤治療性疫苗。作為公司長期研發戰略的重要支柱,該平臺已實現顯著突破。2024年8月,雲頂新耀啟動一款個性化腫瘤疫苗EVM16的研究者發起的臨床試驗项目(IIT),該研究由北京大學腫瘤醫院和復旦大學附屬腫瘤醫院發起。此外,公司還在積極推進基於mRNA的體內CAR-T專案,用於癌症和自身免疫性疾病的治療,不斷拓展其研發管線的潛在應用。本週一,雲頂新耀股價創下52周新高,盤中最高達49.7港元,收盤47.85港元。自中期業績公佈以來,股價已實現翻倍,充分體現了市場對公司未來發展的強烈信心。通過「雙輪驅動」戰略,雲頂新耀持續聚焦未被滿足的醫療需求,尤其在腎病等關鍵領域表現出色,並以EVER001等突破性療法推動業務增長。憑藉強勁的財務勢頭和清晰的戰略規劃,雲頂新耀正穩步邁向可持續增長,為患者和股東創造長期價值。 Copyright 2024 亞太商訊 via SeaPRwire.com.
More

Everest Medicines: Accelerating Innovation in Renal Disease to Forge a Path Toward Biopharma Leadership

HONG KONG, Dec 11, 2024 - (ACN Newswire via SeaPRwire.com) – As reported by the South China Morning Post today, Everest Medicines (HKEX 1952.HK) is accelerating its journey to become a leading biopharmaceutical company in the Asia-Pacific region, driven by robust R&D capabilities and exceptional commercialization expertise.Breakthroughs in Renal Disease Innovation with EVER001On December 4, Everest Medicines announced positive results in preliminary analysis of Phase 1b/2a clinical trial of EVER001, its next-generation, globally owned covalent reversible Bruton’s Tyrosine Kinase (BTK) inhibitor. The trial focuses on primary membranous nephropathy (pMN), a common pathological type of nephrotic syndrome in adults with significant unmet medical needs. The prevalence of pMN in China has been increasing, making it the second most common cause of nephrotic syndrome after IgA nephropathy (IgAN). Currently, there are approximately 2 million patients with pMN in China, 80,000 to 100,000 in the United States, 80,000 in Europe, and 40,000 in Japan,with incidence rates rising in recent years, reflecting its growing global disease burden.Unlike traditional covalent irreversible BTK inhibitors, EVER001 employs a novel covalent reversible mechanism that combines strong target binding with excellent selectivity, significantly reducing off-target toxicity. Positive results in preliminary analysis revealed promising outcomes, with over 90% reductions in anti-PLA2R antibodies and substantial improvements in proteinuria. Additionally, patients in the low-dose cohort who have completed 36 weeks of treatment, 81.8% achieved overall clinical remission, and 91% achieved immunological complete remission. In the high dose cohort, 85.7% patients achieved overall clinical remission and all patients achieved immunological complete remission by week 24. With no currently approved treatments for pMN, EVER001 represents a potentially best-in-class therapeutic candidate. These results highlight EVER001’s potential to deliver best-in-class efficacy and safety, making it a promising treatment not only for pMN but also for a range of other autoimmune glomerular diseases, including lupus nephritis (LN), IgAN, Minimal Change Disease (MCD), and focal segmental glomerulosclerosis (FSGS).With broad indication potential, rising disease prevalence, and Everest Medicines’ global rights, EVER001 represents a high-value asset in a “Blue Ocean” area with significant commercial potential. Kidney disease therapeutics have become a hotspot for innovation and investment in recent years, attracting major multinational pharmaceutical companies. For example, Vertex Pharmaceuticals acquired Alpine Immune Sciences this April for $4.9 billion to access its kidney autoimmune disease therapies. Similarly, Novartis acquired Chinook Therapeutics in June 2023 for $3.5 billion, gaining access to two late-stage treatments for rare, severe chronic kidney diseases.Driving Commercial Success with a Dual-Engine StrategyEverest Medicines continues to strengthen its leadership in nephrology with NEFECON(R), the first FDA-approved treatment for IgAN and the first etiological therapy for IgAN in China. Its inclusion in the 2024 National Reimbursement Drug List (NRDL) marks a significant milestone, enhancing patient accessibility and driving market penetration starting January 1, 2025. Since its commercial launch in May 2024, NEFECON(R) has generated RMB167 million in sales within its first month. The product is also approved in Macau, Hong Kong, Taiwan, South Korea, and Singapore, further cementing Everest’s expertise in nephrology.Everest’s diversified portfolio also includes XERAVA(R) and VELSIPITY(R). XERAVA(R), a novel broad-spectrum antibiotic, demonstrated an overall effectiveness rate of 90.9% after three days of treatment in the "Comprehensive Evaluation Project on the Clinical Application of Eravacycline", contributing RMB134 million in revenue in H1 2024. VELSIPITY(R), approved under the "Hong Kong and Macau Medicine and Equipment Connect" policy, is now available in three designated medical institutions within the Greater Bay Area. It has also received approvals in Macau and Singapore, with an NDA accepted in Hong Kong and plans for an NDA submission in Mainland China by year-end.Everest is accelerating innovation through its proprietary mRNA platform, a cornerstone of its long-term R&D strategy. In August 2024, Everest launched an Investigator-Initiated Clinical Trial for EVM16, a personalized mRNA cancer vaccine, at Peking University Cancer Hospital and Fudan University Cancer Hospital. The company is also advancing mRNA-based in vivo CAR-T programs for cancer and autoimmune diseases, expanding its pipeline’s potential.As of now, Everest Medicines reached a 52-week high of HKD 49.7, closing at HKD 47.85. Since announcing its mid-year results, the stock price has more than doubled, reflecting strong investor confidence. With its dual-engine strategy, Everest has positioned itself as a rising leader in the global biopharmaceutical industry, focusing on unmet medical needs, particularly in renal diseases, and breakthrough therapies like EVER001. Supported by strong financial momentum and a clear vision, Everest is poised for sustainable growth and lasting value for patients and shareholders. Copyright 2024 ACN Newswire via SeaPRwire.com.
More
Combating customer harassment: Fujitsu, Toyo University and Kokoro Balance Research Institute launch field trial on AI-powered training program JCN Newswire

Combating customer harassment: Fujitsu, Toyo University and Kokoro Balance Research Institute launch field trial on AI-powered training program

Tokyo and Kawasaki, Japan, Dec 11, 2024 - (JCN Newswire via SeaPRwire.com) - Fujitsu Limited, Toyo University Incorporated Educational Institution (Toyo University) and Kokoro Balance Research Institute today announced the commencement of a field trial on December 3, 2024, to develop a Training Program for Coping with Customer Aggression. This program leverages AI and incorporates insights from criminal psychology and mental health to tackle the growing societal issue of customer harassment, i.e., unreasonable or abusive behavior directed at staff by customers and clients.The program utilizes the “AI Tool for Experiencing Customer Aggression” developed using Fujitsu's generative AI technology, behavior change support technologies and Toyo University's expertise in criminal psychology. Fujitsu’s AI tool provides interactive feedback through the use of AI avatars and clarifies actions that can be taken to enhance participants' customer harassment response skills. To evaluate the program's effectiveness, Kokoro Balance Research Institute will leverage its mental health expertise to develop new psychological scales measuring customer service skills, stress management, and overall customer harassment response capabilities. Furthermore, the research partners will carry out a field trial with call center employees at Fujitsu Communication Services Limited (CSL), analyzing changes in participants' customer service skills, stress management, engagement, and subjective productivity to ensure the program's scientific validity.The full program is targeted for launch in fiscal 2025 with the goals of reducing the psychological burden of working people in customer service roles and contributing to the creation of safe and supportive work environments.BackgroundCustomer harassment has become a serious social issue. A recent survey revealed that 46.8% of service industry workers have encountered customer harassment in the past two years, with nearly half experiencing lasting physical and mental health consequences.In response, the Ministry of Health, Labour and Welfare added mental health issues related to customer harassment to its work-related injury recognition criteria in September 2023. Furthermore, the Tokyo Metropolitan Assembly passed Japan's first customer harassment prevention ordinance in October 2024. The growing national and local government efforts are driving increased organizational responsibility for employee protection.Field Trial PeriodDecember 3, 2024 to March 31, 2025Figure 1: Overview diagram of the field trial Comment from Akiko Yamada, Head of the Converging Technologies Laboratory of Fujitsu Research, Fujitsu Limited:We have been pursuing research in converging technologies, combining cutting-edge digital technology with knowledge from humanities and social sciences to solve various social issues. This new initiative combines generative AI, behavioral change support technology, criminal psychology, and mental health expertise to tackle the significant social problem of customer harassment and secure the well-being of working people.Comment from Prof. Masayuki Kiriu, Dean, Faculty of Sociology, Toyo University:By incorporating psychological scales and stress measurement indicators into the "AI Tool for Experiencing Customer Aggression”, we expect to create a practical and effective customer harassment response training program for customer service personnel. This will significantly contribute to solving current customer harassment issues. We anticipate the emergence of new social contributions through converging technology in this pilot program.Comment from Kyoko Shimada, Representative Director, Kokoro Balance Research Institute:Customer harassment can inflict deep emotional wounds on employees. While eradication may be impossible, we can reduce its impact through organizational efforts. This research aims to strengthen organizations by focusing on employee mental health and response capabilities. By using globally recognized psychological scales and effective evaluation criteria, we aim to make this program scientifically sound, useful, and applicable for employees.About FujitsuFujitsu’s purpose is to make the world more sustainable by building trust in society through innovation. As the digital transformation partner of choice for customers in over 100 countries, our 124,000 employees work to resolve some of the greatest challenges facing humanity. Our range of services and solutions draw on five key technologies: Computing, Networks, AI, Data & Security, and Converging Technologies, which we bring together to deliver sustainability transformation. Fujitsu Limited (TSE:6702) reported consolidated revenues of 3.7 trillion yen (US$26 billion) for the fiscal year ended March 31, 2024 and remains the top digital services company in Japan by market share. Find out more: www.fujitsu.com.Press Contacts:Fujitsu LimitedPublic and Investor Relations DivisionInquiriesToyo UniversityToyo University General Affairs Department, Public Relations DivisionPhone: 03-3945-7571Reception hours: 9:00-18:00 JST (excluding Saturdays, Sundays, holidays, and university-designated holidays)E-mail: mlkoho@toyo.jpKokoro Balance Research InstituteE-mail: info@kokorobalance.jp Copyright 2024 JCN Newswire via SeaPRwire.com.
More
China Medical System: First Prescriptions for Innovative Drug Lumeblue(R) Issued in China SeaPRwire

China Medical System: First Prescriptions for Innovative Drug Lumeblue(R) Issued in China

SHENZHEN, CHINA, Dec 9, 2024 – (ACN Newswire) – On 6 December, China Medical System Holdings Limited (“CMS” or the “Group”) is pleased to announce that the first prescriptions for the innovative drug Lumeblue® (Methylthioninium Chloride Enteric-coated Sustained-release Tablets) (the “Product”) have been issued in China, which marks that the first oral methylthioninium chloride enteric-coated sustained-release tablets in China has officially entered clinical application. The Product is indicated for enhancing visualization of colorectal lesions in adult patients undergoing screening or surveillance colonoscopies. Lumeblue® is an oral diagnostic drug that uses patented multi-matrix (MMXTM) technology to deliver active substances directly to the colon and release them locally in a controlled manner. As an enhancer dye, the Product increases the contrast between colorectal lesions and healthy mucosa. The results of the Phase III clinical trial in China show that the Product can significantly improve the detection rate of non-polypoid colorectal lesions (the primary endpoint of the study), leading to an improved detection rate of dangerous lesions such as non-polypoid adenomas (the secondary endpoint)[1]. In addition, the Product can be taken during the bowel preparation step, ensuring that colorectal staining is completed by the time colonoscopy is conducted. This not only enhances the detection rate of colorectal lesions but also potentially simplifies the colonoscopy procedure, making the examination more efficient and improving the screening benefits. According to the diagnosis and treatment data of the Digestive Endoscopy Branch of the Chinese Medical Association, approximately a total of 28 million gastroenteroscopies were completed nationwide in 2012, including 5.83 million colonoscopies. In 2019, approximately 38.73 million gastroenteroscopies were completed nationwide, an increase of 34.62% compared with 2012[2]. The Expert consensus on the early diagnosis and treatment of colorectal cancer in China (2023 edition) recommends colorectal cancer screening for individuals aged 40 to 74[3]. Based on the China Statistical Yearbook (2023), the total population of this age group in China is 643.36 million[4]. With the popularization of early colorectal cancer screening in China, the number of colonoscopies performed is expected to have significant growth potential in the future. Early diagnosis and removal of lesions are crucial for prevention. Lumeblue® provides an innovative solution for colorectal disease screening and management in response to this growing demand. The Product has been approved by the European Medicines Agency (EMA) to be commercialized in the European Union under the trade name Lumeblue® in August 2020. The Group obtained an exclusive license for the Product from Cosmo Technologies Ltd., a fully-owned subsidiary of Cosmo Pharmaceuticals NV, on 3 December 2020. Following its approval in China in June 2024, CMS worked collaboratively across its business segments to ensure the rapid importation of the first batch of products. The Group has also actively leveraged its existing gastroenterology portfolio and resources to orderly advance the commercialization and academic promotion of Lumeblue®, facilitating its successful prescriptions launch in China. With this milestone, CMS’s five innovative drugs have been successfully approved in China and fully entered clinical application. This achievement demonstrates the Group’s ongoing capability of innovation transformation, while reflecting CMS’s commitment to focusing on medical value and fulfilling its corporate social responsibility. Looking ahead, CMS will continue to be patients-centered, efficiently advancing the clinical development and commercialization of innovative products. The Group is dedicated to improving the accessibility and affordability of innovative drugs, benefiting a broader patient population. About CMS CMS is a platform company linking pharmaceutical innovation and commercialization with strong product lifecycle management capability, dedicated to providing competitive products and services to meet unmet medical needs. CMS focuses on the global first-in-class (FIC) and best-in-class (BIC) innovative products, and efficiently promotes the clinical research, development and commercialization of innovative products, enabling the continuous transformation of scientific research into clinical practices to benefit patients. CMS deeply engages in several specialty therapeutic fields, and has developed proven commercialization capabilities, extensive networks and expert resources, resulting in leading academic and market positions for its major marketed products. CMS continues to promote the in-depth development of its advantageous specialty fields and expand business boundaries. While strengthening the competitiveness of the cardio-cerebrovascular/gastroenterology business, CMS independently operates its dermatology and medical aesthetics business, and ophthalmology business, aiming to gain leading positions in specialty therapeutic fields, whilst enhancing the scale and efficiency. At the same time, CMS has expanded its business territory to the Southeast Asian market, striving to become a “bridgehead” for global pharmaceutical companies to enter the Southeast Asian market, further escorting the sustainable and healthy development of the Group. References: 1. The results of the Product’s Phase III clinical trial in China were published and are available at: https://web.cms.net.cn/en/2022/12/positive-results-for-china-phase-iii-clinical-trial-of-methylthioninium-chloride-enteric-coated-sustained-release-tablets/ 2. Data from the Digestive Endoscopy Branch of the Chinese Medical Association 3. Early Diagnosis and Treatment Group of the Chinese Society of Oncology. “Expert Consensus on Early Diagnosis and Treatment of Colorectal Cancer in China (2023 Edition).” Chinese Medical Journal, 2023, 103(48): 3896-3908. DOI: 10.3760/cma.j.cn112137-20230804-00164 4. National Bureau of Statistics. (2023). China Statistical Yearbook 2023. Retrieved from https://www.stats.gov.cn/sj/ndsj/2023/indexch.htm CMS Disclaimer and Forward-Looking Statements This press release is not intended to promote any products to you and is not for advertising purposes. This press release does not recommend any drugs, medical devices and/or indications. If you want to know more about the diagnosis and treatment of specific diseases, please follow the opinions or guidance of your doctor or other medical and health professionals. Any treatment-related decisions made by healthcare professionals should be based on the patient’s specific circumstances and in accordance with the drug package insert. This press release which has been prepared by CMS does not constitute any offer or invitation to purchase or subscribe for any securities, and shall not form the basis for or be relied on in connection with any contract or binding commitment whatsoever. This press release has been prepared by CMS based on information and data which it considers reliable, but CMS makes no representation or warranty, express or implied, whatsoever, and no reliance shall be placed on, the truth, accuracy, completeness, fairness and reasonableness of the contents of this press release. Certain matters discussed in this press release may contain statements regarding the Group’s market opportunity and business prospects that are individually and collectively forward-looking statements. Such forward-looking statements are not guarantees of future performance and are subject to known and unknown risks, uncertainties and assumptions that are difficult to predict. Any forward-looking statements and projections made by third parties included in this press release are not adopted by the Group and the Company is not responsible for such third-party statements and projections.
More
FxPro Group Announces the Launch of BankPro: A Private Digital Banking Solution SeaPRwire

FxPro Group Announces the Launch of BankPro: A Private Digital Banking Solution

Nassau, the Bahamas – December 11, 2024 – (SeaPRwire) – FxPro Group, a global leader in financial services and trading, has launched BankPro, a cutting-edge Private Digital Bank designed to redefine digital financial solutions for individuals and corporations. BankPro combines private banking services with advanced investment and trading capabilities, offering clients a seamless, all-in-one application tailored to their financial needs. The launch of BankPro underscores FxPro Group’s commitment to innovation and excellence, leveraging its 25 years of expertise and $120 million in Tier 1 company capital to introduce a next-generation digital banking solution. BankPro is regulated by the Central Bank of The Bahamas and operates with the highest standards of security and compliance. Key Features of BankPro: Multi-Currency Accounts BankPro provides access to over 24 currencies, enabling effortless international transactions at competitive exchange rates. Clients can manage their finances globally with a single account designed for both personal and corporate use. Visa Platinum Cards Clients can access exclusive Visa Platinum cards, offering customizable spending limits, global acceptance, and enhanced security. Additionally, instant virtual cards provide a secure and efficient solution for online transactions, making BankPro a versatile option for all financial activities. Global Banking with Flat Fees BankPro simplifies international banking with flat-fee structures, ensuring transparent and predictable costs. This approach is particularly advantageous for high-value transactions, providing clarity and value for clients engaged in global business and personal finance. Comprehensive Investment and Trading Platform BankPro integrates investment and trading capabilities, allowing clients to manage and grow their portfolios within the same platform. Key features include: Investing in over 2,100 Stocks and ETFs: Clients gain access to major exchanges, including NYSE, Nasdaq, LSE, XETRA, and Euronext. Real-Time Market Data: Active subscriptions include free live pricing from Nasdaq and LSE. Through FxPro Global Markets Ltd., clients can also trade over 200 Derivatives across Forex, Commodities, Metals, Indices, Stocks, and ETFs, enabling portfolio diversification and risk management. Corporate Banking Solutions BankPro offers tailored services for businesses, including multi-currency accounts, streamlined expense management tools, and advanced treasury management solutions. Corporate clients benefit from high-spending Visa Platinum cards, detailed reporting tools, and access to flexible investment options. A Strong Foundation in the Bahamas BankPro operates from its state-of-the-art headquarters in Lyford Cay, Nassau. The facility reflects the company’s commitment to The Bahamas as a central hub for its operations. The company also has an office in the City of London, UK. As a fully regulated entity, BankPro prioritizes security and reliability, holding a professional membership with the Association of International Banks and Trust Companies. The company’s regulatory foundation ensures robust protection for clients, complemented by advanced digital onboarding tools and fraud prevention measures. These features, combined with the FxPro Group’s legacy of excellence, make BankPro a trusted partner for financial services. About FxPro Group With 25 years of experience, the FxPro Group is a global leader in financial services, offering trading solutions across Forex, Commodities, and more. With a presence in over 170 countries and $200+ million invested in elite sponsorships, FxPro has earned over 120 industry awards for its innovative technology and reliable services. The launch of BankPro marks the Group’s expansion into digital private banking, combining its expertise in trading with cutting-edge financial solutions designed for the modern client. To know more please contact +1 242 603 2226. Media Contact Brand: BankPro Limited Contact: Media team Email: info@bankpro.com Website: https://www.bankpro.com The article is provided by a third-party content provider. SeaPRwire ( https://www.seaprwire.com/ ) makes no warranties or representations in connection therewith. Sectors: Top Story, Corporate News SeaPRwire provides real time press release distribution for companies and organizations to 6,500+ media outlets & 3.5 million professional desktops in 90 regions. It distributes press releases in different languages, including: IndonesiaFolk, IndoNewswire, SEATribune, IDNewsZone, LiveBerita, DailyBerita, TaiwanPR, SinchewBusiness, AsiaEase, BuzzHongKong, SingapuraNow, TIHongKong, TaipeiCool, TWZip, AsiaFeatured, dePresseNow, THNewson, KULPR, VNFeatured, MENAEntry, HunaTimes, DubaiLite, ArabicDir, BeritaDaring, TekanAsia, JamKopi ...
More

順豐控股進軍港股 書寫國際化發展新篇章

香港, 2024年12月10日 - (亞太商訊 via SeaPRwire.com) - 據經濟日報報道,隨著全球企業供應鏈的重塑、中國企業出海以及跨境電商的推動,市場對更高效、更靈活、更綜合的物流服務的需求不斷攀升。順豐控股股份有限公司(「順豐控股」,股份代號:6936.HK)以其獨特的業務模式和強大的網絡優勢,積極佈局國際物流服務,投身於時代革新發展的浪潮中。根據弗若斯特沙利文,按2023年收入計,順豐控股是中國及亞洲最大的綜合物流服務提供商,也是全球第四大綜合物流服務提供商,僅次於聯合包裹服務公司(UPS)、敦豪(DHL)和聯邦快遞(FedEx)。公開資料顯示,順豐控股連續多年位居《財富》世界500強企業之列。2024年,公司獲評《財富》最受讚賞的中國公司第二位,且連續8年上榜「《財富》最受讚賞的中國公司」。11月27日,順豐控股登陸港交所,掀開國際化發展新篇章。夯實物流基礎網絡 持續迎來盈利兌現順豐控股最早於2010年即開始運營國際業務,主要服務中國客戶的出境物流需求。如今,隨著中國企業出海,國際供應鏈蘊含著重大轉型機遇。2021年,公司攜手嘉里物流,進一步強化了在東南亞的本土及跨境快遞、國際供應鏈和國際貨代能力。通過與嘉里物流的融通,其國際綜合物流能力和客戶基礎得到進一步強化,為實現國際拓展的戰略和願景提供了重要助力。根據弗若斯特沙利文報告,按國際收入計,2023年順豐的國際業務規模已在所有亞洲綜合物流服務提供商中排名第一。值得關注的是,經過多年投入後,順豐控股已度過資本開支的高峰期,迎來更高質量增長週期。一方面,業務規模擴張持續攤薄基礎設施邊際成本,提升其營業利潤率。另一方面,公司新業務陸續進入"收獲期",提供公司盈利彈性。具體而言,經濟產品體系升級,助力利潤穩步增長;大件業務於2022年淨利潤轉盈,2023年在降本提效作用下盈利能力持續增厚;同城業務於2023年首次實現全年盈利,2024年延續高增長。得益於此,順豐控股盈利能力持續增強,2024年前三季度,其收入同比增加9.4%,淨利潤同比增加28.0%。淨利率達到3.7%,同比提升了0.5個百分點。未來,在上述因素的共同推動下,公司盈利能力有望進一步增強。加速推進國際業務 打開中長期成長空間對於順豐控股而言,從亞洲到全球,是其發展的必然。為此,公司積極參與建設鄂州貨運樞紐,作為亞洲第一、全球第四座以貨運為主的物流樞紐,鄂州貨運樞紐的投產將進一步擴大公司與同業在配送時效以及網絡方面的差異化優勢,促進公司降本增效,為國際業務拓展奠定了堅實的基礎。隨著位於鄂州貨運樞紐的分揀及轉運中心投入運營,憑藉豐富的產品組合、綜合的全球能力、併購經驗、卓越的運營及精益的成本管控,順豐控股能夠有效整合市場並把握國內外的市場機遇。順豐控股高管曾表示,赴港上市是出於國際化的長遠考慮,最主要目的是利用全球化資本,實現規模快速擴張。本次上市,順豐控股計劃將募集資金的45%用於加強其國際及跨境物流能力,此將進一步提升公司國際產品的廣度及深度,助力公司國際業務加速拓展。同時,H股上市也有助於提升公司品牌影响力及市場竞争力。在豐富的物流網絡、領先的成本優勢和綜合物流能力的支撐下,順豐控股有望搶佔更大的全球市場份額,推動公司投資價值的不斷增長。 Copyright 2024 亞太商訊 via SeaPRwire.com.
More
VisiRose Introduces Revolutionary Therapy for Severe Eye Infections ACN Newswire

VisiRose Introduces Revolutionary Therapy for Severe Eye Infections

KNOXVILLE, Tenn., Dec 10, 2024 - (ACN Newswire via SeaPRwire.com) - VisiRose, a clinical-stage biotechnology company, is introducing Rose Bengal Photodynamic Antimicrobial Therapy (RB PDAT), a groundbreaking, non-invasive investigational treatment for infectious keratitis and other serious eye infections developed by the University of Miami Miller School of Medicine's Bascom Palmer Eye Institute (BPEI). VisiRose, a newly launched company of Provectus Biopharmaceuticals (OTCQB:PVCT) and the University, is focused on commercializing this innovative ocular research by combining a formulation of Provectus's pharmaceutical-grade bioactive synthetic small molecule Rose Bengal Sodium (RBS) and BPEI's light-based medical device to treat eye infections caused by bacteria, fungi, and parasites.RB PDAT offers a potential solution to the growing global problem of antimicrobial resistance (AMR), providing a broad-spectrum ocular therapy that may be safe, effective, and cost-efficient. The treatment has shown rapid infection resolution and improved patient outcomes in clinical trials across the U.S., India, Brazil, and Mexico."RB PDAT is a revolutionary, non-invasive treatment showing remarkable promise for patients with severe infectious keratitis. This innovative therapy harnesses the power of light to combat infection and offers new hope for preserving vision," said Jean-Marie Parel, IngETS-G, Ph.D., FAIMBE, FARVO, Director and co-founder of the Ophthalmic Biophysics Center at BPEI.Guillermo Amescua, M.D., Professor of Clinical Ophthalmology, Medical Director of the Ocular Microbiology Laboratory, and a board-certified ophthalmologist at BPEI added, "VisiRose is crucial for translating the innovation of RB PDAT from the laboratory to a widely accessible treatment, ultimately benefiting countless patients worldwide.""VisiRose is the bridge that connects innovation with impact. It enables us to bring the hope of RB PDAT to patients who desperately need it, transforming lives and shaping the future of eye care," said Ed Pershing, Chairman of the Board of Directors of VisiRose and Provectus.Dominic Rodrigues, Acting CEO of VisiRose added, "RB PDAT offers a beacon of hope for patients facing the threat of vision loss from infectious keratitis. This innovative therapy, with its targeted action and dual benefits, represents a significant advancement in eye care, paving the way for a brighter future for those struggling with this challenging condition."In more than 500 patients, RB PDAT has shown promising results in treating severe eye infections where traditional therapies have failed. VisiRose is poised to address a significant gap in the $60 billion global ophthalmic market, focusing on regions and populations impacted by rising AMR and the lack of access to effective treatments.About VisiRoseVisiRose is a newly launched, clinical-stage biotechnology company of the University of Miami and Provectus Biopharmaceuticals, focused on commercializing the Miller School of Medicine's Bascom Palmer Eye Institute and its Ophthalmic Biophysics Center's innovative ocular research using Provectus's bioactive synthetic small molecule Rose Bengal Sodium (RBS). For more information, please visit: https://visirose.com.About Bascom Palmer Eye InstituteThe Bascom Palmer Eye Institute, part of the University of Miami Health System, is consistently ranked #1 in ophthalmology in the U.S. by U.S. News & World Report. Known for its cutting-edge research and clinical excellence, Bascom Palmer provides world-class care across all ophthalmic subspecialties and is at the forefront of developing innovative treatments for eye diseases. With a commitment to advancing both patient care and medical research, it is recognized globally as a leader in ophthalmology. For more information, please visit: https://umiamihealth.org/en/bascom-palmer-eye-institute.About Provectus BiopharmaceuticalsProvectus Biopharmaceuticals (OTCQB: PVCT) is a clinical-stage biotechnology company developing immunotherapy medicines for different diseases that are based on a class of bioactive synthetic small molecules called halogenated xanthenes. The Company's lead molecule is named Rose Bengal Sodium. Provectus's drug platform includes:Clinical development programs in oncology, dermatology, and ophthalmology,In vivo proof-of-concept programs in oncology, hematology, full-thickness cutaneous wound healing, and canine cancers, andIn vitro discovery programs in infectious diseases, tissue regeneration and repair, and several proprietary targets.Information about the Company's clinical trials can be found at the National Institutes of Health (NIH) registry, www.clinicaltrials.gov. For more information, please visit: www.provectusbio.com.For Media Inquiries:VisiRose, Inc.E: contact@visirose.comW: visirose.comContact:VisiRose, Inc.Dominic RodriguesActing Chief Executive OfficerE: rodrigues@visirose.comSOURCE: VisiRose Copyright 2024 ACN Newswire via SeaPRwire.com.
More
Provision of the First Template Function Adapted to the IFRS Sustainability Disclosure Standards in Japan (IFRS S1 and S2) on the Sustainable Finance Platform JCN Newswire

Provision of the First Template Function Adapted to the IFRS Sustainability Disclosure Standards in Japan (IFRS S1 and S2) on the Sustainable Finance Platform

TOKYO, Dec 10, 2024 - (JCN Newswire via SeaPRwire.com) - The Association for Promotion of Sustainable Finance Platform (AP-SFPF) and Hitachi, Ltd. (Hitachi) today announced that we will begin providing the first template feature adapted to the IFRS sustainability disclosure standards in Japan (IFRS S1 and S2*1) formulated by the International Sustainability Standards Board (ISSB), on the Sustainable Finance Platform - Engagement Support Service (SFP-ESS), a digital platform that promotes ESG investing by establishing seamless connections between asset management companies and listed companies.Specifically, Hitachi's SFP-ESS, developed under license from the IFRS Foundation, will be enhanced with a templatedesigned to facilitate reporting in accordance with IFRS S1 and S2 and the SASB Standards*2 (Templates). AP-SFPF will offer the Templates to asset management companies and listed companies in Japan as the service provider.By starting to provide the Templates, AP-SFPF and Hitachi will support listed companies in Japan in their disclosure of information in conformance with IFRS S1 and S2 and communication between listed companies and assetmanagement companies. This will enable global institutional investors to properly evaluate sustainability-conscious corporate activities in the ESG perspective and contribute to the enhancement of the companies' corporate value.AP-SFPF is a general incorporated association that was established to connect diverse stakeholders andpromote effective and efficient communication, solving issues and considering projects to contribute to the continued development of the ESG market. It was established in July 2023 by eight companies, which mainly include financial institutions: MS&AD Insurance Group Holdings, Inc., Sompo Japan Insurance Inc., Tokio Marine & Nichido Fire Insurance Co., Ltd., Nippon Life Insurance Company, Hitachi, Ltd., Mizuho Bank, Ltd., Sumitomo Mitsui Banking Corporation, and MUFG Bank, Ltd.Background of the start to adapt the SFP-ESS for IFRS S1 and S2Recently, investors' interest in companies' sustainability initiatives has been growing and companies are implementing sustainability initiatives and disclosing information about them. However, there are various disclosure standards in Japan and global. This has created an issue regarding disclosures. The people in charge of disclosing information,especially people at listed companies engaging in business globally, are not sure which standards to refer to and unable to determine investors' expectations regarding the disclosure of information, in addition to being short of resources. To solve this situation, the ISSB announced IFRS S1 and S2 in June 2023 as global baseline standards forthe disclosure of sustainability-related information.In Japan, the Sustainability Standards Board of Japan (SSBJ) is formulating the Japanese version of S1 and S2 (the SSBJ standards), which are made to comply with all of the requirements of IFRS S1 and S2, the standards fordisclosing sustainability-related informationin Japan. The finalized standards are planned to be published by March 2025. In addition, the Financial ServicesAgency made it mandatory to disclose sustainability-related information in securities reports in the fiscal year ended March 31, 2023. It is also considering the gradual application of the SSBJ standards to companies listed on the PrimeMarket starting in the fiscal year ending March 31, 2027. Therefore, listed companies are facing urgent tasks, such asthe collection of sustainability-related information and the development of a disclosure process in line with IFRS S1and S2, to prepare for the disclosure of information becoming mandatory in the future and to enhance their corporate value.In response, AP-SFPF exchanged opinions with more than 100 companies, including asset management companiesand listed companies, and began to offer a beta version of the SFP- ESS and verify its value in October 2023 to reduce the workload of the people at listed companies in charge of disclosing information and promote ESG investingin Japan. By using the Templates to adapt the SFP-ESS to IFRS S1 and S2, AP-SFPF and Hitachi will help listed companies smoothly disclose ESG information and contribute to improving their corporate value.Outline of SFP-ESSThe SFP-ESS is a two-sided platform on which asset management companies and listed companies making ESG investments are connected seamlessly to deepen their mutual understanding of each other. Asset managementcompanies present their needs regarding the ESG information it expected that listed companies disclose in line with theSASB*2 Standards. Listed companies refer to this registered information, which enables them to understand the needs of asset management companies and use the information when formulating their disclosure policies.Listed companies enter their data into the platform and send it, publishing it alongside comments by following the disclosure items in the Templates. This facilitates asset management companies' side-by-side comparison of listedcompanies as the viewers and also enables them to understand data, including the details.Features of the Templates adapted to IFRS S1 and S2Regarding IFRS S1 and S2, documents explaining the disclosure standards themselves, the IFRS Sustainability Disclosure Taxonomy*3, and support materials including a guide for the voluntary application of ISSB Standards havebeen published. However, Japanese documents are limited, and each company is left to decide how they will disclose the information they should disclose in their integrated reports and other reports. To support the practical tasks done by these listed companies, the Templates come with an input interface available in Japanese, so that digital data can be entered and saved on the platform in accordance with definitions in the taxonomy. Specifically, the Templates helplisted companies understand and respond to IFRS S1 and S2 using the following three features.1. Disclosure items classified into three categories (major categories, intermediate categories, and subcategories)The IFRS Sustainability Disclosure Taxonomy information is classified in detail into four core classifications (governance, strategy, risk management, and metrics and targets). However, the hierarchical structure differs from item to item. In response, a creative measure was devised to streamline data entry by the people in charge ofthe disclosure of information at listed companies by classifying the information into major categories,intermediate categories and subcategories visualizing the hierarchical structure of the information. This helps the people in charge of disclosing information at companies understand information collection based on the definitions in IFRS S1 and S2 without difficulty.2. Supplementary information from the IFRS Foundation regarding each disclosure item is provided when viewing the Templates.The IFRS Foundation, provides application guidance which companies may want to refer to when entering information into the Templates.3. Tables styles and options enabling an intuitive understanding of the information that needs to be disclosed are availableOptimal table styles are provided on an item-by-item basis to enable people to intuitively understand and enter the information required for each disclosure item. For example, there is an appropriate answer space for itemsthat are yes or no questions. In addition, for items which require that risks be described, there is a multiple-choice section about the type of risk (physical or transition) and the time frame (short, medium, or long term), in addition to the space for describing the risk. This prevent the omission of information or the provision of insufficient information.Future developmentMoving forward, AP-SFPF and Hitachi will broadly expand the SFP-ESS with the Templates to listed companies andtalk with multiple listed companies preparing to comply with IFRS S1 and S2 ahead of others. It will thus collect opinionsand requests regarding the improvement of the convenience of the Templates and develop the Templates so that we are more useful and adapted to IFRS S1 and S2.We will also work to functionally enhance the SFP-ESS in addition to developing the Templates. Specifically, they moveforward with consideration and development to provide service features which will be needed in the promotion ofthe disclosure of information, dialogue, and engagement between asset management companies and listedcompanies, such as a feature enabling asset management companies to register their information disclosure needs, and to release these features one by one. We also plan to incorporate the finalized SSBJ standards which will be published by the SSBJ by March 2025.Speaking at Director of Earned Revenue, IFRS Sustainability, Eli Reisman, said:“The IFRS Foundation welcomes Hitachi as a licensee of its standards. The IFRS Foundation encourages companiesvoluntarily applying IFRS S1 and IFRS S2, in addition to the progress being made towards regulatory adoption or other use of IFRS S1 and IFRS S2 happening in 25+ jurisdictions globally. In order to facilitate this corporate disclosure, it’s imperative that various services and tools integrate the ISSB standards to support this process."Yasuki Imai, Vice President and Executive Officer, Head of Digital Systems & Services APAC Business, and CEO of Financial Institutions Business Unit, Hitachi, Ltd, said:“In line with this approach to sustainability reporting, Hitachi and its only reseller of SFP-ESS, The Association forPromotion of Sustainable Finance Platform, aim to facilitate the application of IFRS S1, S2, and SASB standards and provide guidance on industry-specific disclosures through the SFP-ESS platform: SFP-ESS is a digital platformdesigned to support companies in their sustainability reporting efforts. This tool is intended to assist companies in navigating the reporting process, with the goal of enhancing the standardization and relevance of ESG reporting.”AP-SFPF member company, Managing Executive Officer, Group Chief Sustainability Officer (CSuO), MS&AD Insurance Group Holdings, Inc., Naomi Motojima said:“MS&AD Insurance Group Holdings, Inc. engages in investment, lending and insurance underwriting activities in consideration with ESG as a signatory to Principles for Sustainable Insurance (PSI) and the Principles for ResponsibleInvestment (PRI). We consider “Symbiosis with global environment ~Planetary Health~” as an important issue forMS&AD group, and we are working on realizing “Action on climate change” and “Improvement of sustainability of natural capital” comprehensively to enhance the resilience of society. We help to solve ESG issues including climate change through insurance underwriting, investment and lending, and of course we also work to reduce our own Greenhouse gas (GHG) emissions. We regard them as missions that we have as an insurance and financing serviceprovider. SFP-ESS is a platform that increases the mutual understanding of companies and financial institutions regarding ESG information disclosure. We hope that using the disclosure templates adapted to S1 and S2, which will be newly implemented, will facilitate the disclosure of information related to companies' ESG activities and lead to investors appropriately evaluating the companies. Further, from the standpoint of an investor, we find the developmentof a platform which enables users to compare the information disclosed by companies using a same index beneficial in the activities for the appropriate evaluation of the activities of the companies. Therefore, we welcome the release of the template feature.”*1 Disclosure standards announced by the IFRS Foundation in June 2023. The standards consist of IFRS S1 (General Requirements for Disclosure of Sustainability-related Financial Information) and IFRS S2 (Climate-related Disclosures).*2 The Sustainability Accounting Standards Board (SASB) Standards provide industry-specific ESG disclosure guidance focused on financial materiality. As of August 2022, the International Sustainability Standards Board (ISSB) of the IFRS Foundation assumed responsibility for the SASB Standards.*3 The IFRS Sustainability Disclosure Taxonomy is a framework for digitally tagging sustainability-related financial disclosures Its goal is to digitalize informationand facilitate investors' and stakeholders' comparison and assessment of companies' sustainability performanceSFP-ESS websitehttps://sfp-ess.org/en/service/About the Association for Promotion of Sustainable Finance Platform (AP-SFPF)The AP-SFPF was established in July 2023 to solve issues and consider projects, with financial institutions playing a leading role, to create new value and contribute to the continued development of the ESG market, eventually resultingin the sustainable development of society through the connection of various stakeholders to each other and the provision of a platform which will facilitate efficient and effective communication related to ESG issues.Member companies: MS&AD Insurance Group Holdings, Inc., Sompo Japan Insurance Inc., Tokio Marine & NichidoFire Insurance Co., Ltd., Nippon Life Insurance Company., Hitachi, Ltd., Mizuho Bank, Ltd., Sumitomo Mitsui Banking Corporation., MUFG Bank, Ltd.Representative: Yoshihiro Kanaoka, Representative Director Location: 1-6-1 Marunouchi,Chiyoda-ku, Tokyo 100-8220, Japan Corporate website: https://sfp-ess.org/en/About Hitachi, Ltd.Hitachi drives Social Innovation Business, creating a sustainable society through the use of data and technology. We solve customers' and society's challenges with Lumada solutions leveraging IT, OT (Operational Technology) and products. Hitachi operates under the 3 business sectors of “Digital Systems & Services” – supporting our customers’ digital transformation; “Green Energy & Mobility” – contributing to a decarbonized society through energy and railway systems, and “Connective Industries” – connecting products through digital technology to provide solutions in various industries. Driven by Digital, Green, and Innovation, we aim for growth through co-creation with our customers. The company’s revenues as 3 sectors for fiscal year 2023 (ended March 31, 2024) totaled 8,564.3 billion yen, with 573 consolidated subsidiaries and approximately 270,000 employees worldwide. For more information on Hitachi, please visit the company's website at www.hitachi.com. Copyright 2024 JCN Newswire via SeaPRwire.com.
More
Fujitsu drives business process improvement at Mitsubishi Electric Engineering using SAP Signavio(R) JCN Newswire

Fujitsu drives business process improvement at Mitsubishi Electric Engineering using SAP Signavio(R)

Fujitsu today announced that it has provided Mitsubishi Electric Engineering with process visualization and analysis services utilizing the process mining(1) capabilities of “SAP Signavio®”(2), a platform that supportsbusiness transformation. Fujitsu consultants also identified areas requiring improvement and offered recommendations for process optimization.Mitsubishi Electric Engineering implemented its current system using SAP S/4HANA® in 2022 and planned a system upgrade for 2025. To optimize costs and efficiency before the upgrade, the company evaluated the effectiveness of its key business processes, such as sales and procurement, focusing on areas for improvement in operational quality and process standardization.To support this evaluation, Fujitsu employed its visualization and analysis service, which continuously monitors, analyses, and evaluates the effects of the current system's implementation. By visualizing the entire business process using log data from the current system, Fujitsu identified bottlenecks and process inconsistencies. Fujitsu consultants, with their deep understanding of SAP solutions, then used this information to propose process improvements.These improvement proposals were then discussed and refined in workshops with Mitsubishi Electric Engineering, leading to a clear identification of business challenges and improvement strategies. This data-driven approach, compared to traditional consulting methods relying solely on client interviews, enabled a rapid clarification of the current situation. This shortened the usual six to twelve-month evaluation phase to approximately one month, allowing more time for in-depth discussions on core business issues.Fujitsu will continue to support Mitsubishi Electric Engineering's process improvement initiatives. Through this collaboration, Fujitsu aims to help various companies achieve continuous process improvement and enhance their ability to adapt to changing business environments.(1) Process mining: Analytical method for discovering, monitoring, and improving actual processes based on easily accessible event logs from existing information systems.(2) SAP Signavio®: Platform provided by SAP SE (Germany) that supports business process management.Fujitsu’s Commitment to the Sustainable Development Goals (SDGs)The Sustainable Development Goals (SDGs) adopted by the United Nations in 2015 represent a set of common goals to be achieved worldwide by 2030.Fujitsu’s purpose — “to make the world more sustainable by building trust in society through innovation” — is a promise to contribute to the vision of a better future empowered by the SDGs.About FujitsuFujitsu’s purpose is to make the world more sustainable by building trust in society through innovation. As the digital transformation partner of choice for customers in over 100 countries, our 124,000 employees work to resolve some of the greatest challenges facing humanity. Our range of services and solutions draw on five key technologies: Computing, Networks, AI, Data & Security, and Converging Technologies, which we bring together to deliver sustainability transformation. Fujitsu Limited (TSE:6702) reported consolidated revenues of 3.7 trillion yen (US$26 billion) for the fiscal year ended March 31, 2024 and remains the top digital services company in Japan by market share. Find out more: www.fujitsu.com.Press ContactsFujitsu LimitedPublic and Investor Relations DivisionInquiries Copyright 2024 JCN Newswire via SeaPRwire.com.
More

中國軍方在台灣周圍大規模部署,傳達「非常簡單」的信息

(SeaPRwire) - 台灣國防官員正對過去24小時內中國海軍艦艇和軍機的大規模部署表示擔憂,稱這種增兵最終可能導致戰爭,因為該地區的緊張局勢持續升高。官員表示,中國已向台灣周邊水域派遣約12艘艦艇和47架軍機,該國正為台灣總統賴清德最近出訪夏威夷和關島(美國領土)後的軍事演習做準備。此行激怒了中國,中國聲稱台灣是其領土。賴清德自5月上任以來,在關島期間曾與美國國會領袖通電話。就在美國批准價值可能達20億美元的對台軍售案幾週後,此行發生,其中包括向台灣交付在烏克蘭經過戰火考驗的先進防空導彈系統和雷達系統。根據美國國務院政治軍事事務局的說法,潛在的軍售方案包括三個國家先進地對空飛彈系統(NASAMS)及相關設備,價值高達11.6億美元。中國共產黨政府承諾將吞併台灣,必要時將動用武力,並幾乎每天都向台灣附近派遣艦艇和軍機。關於最新的兵力增強,台灣謝吉勝中將表示,中國海軍正在構築兩道防線——一道在台灣周邊,另一道在第一島鏈之外,第一島鏈從日本南部延伸到台灣,再到菲律賓。他指的是台灣海峽(台灣與中國大陸之間的水域),並說:「他們發出的信息非常簡單:台灣海峽是我們的。」台灣官員表示,此次部署未經宣布,並稱目前的行動是訓練演習。然而,謝吉勝警告說,訓練可以演變成演習,演習可以演變成戰爭。他說:「目前處於例行訓練狀態。但在常規訓練的狀態下,它能夠動員如此大規模的軍隊,在如此廣闊的區域進行演習。」台灣軍方高度戒備,於週一設立緊急應變中心,並宣布中國東部沿海七個區域的飛行限制。這些限制將持續到週三。美國通過與台灣官員的軍事協議、行動和外交互動,一再表示支持台灣。近年來,美國官員(例如前眾議院議長南希·佩洛西)與台灣官員會面,北京隨之發出 sabre-rattling(戰爭威脅)的反應。佩洛西於2021年對台灣進行了罕見訪問,中國則以在台灣周圍舉行實彈軍事演習作為回應。這些演習發生在當時的台灣總統蔡英文在加州會見前眾議院議長凱文·麥卡錫之後。中國視賴清德為分裂主義者,還在賴清德5月就職和10月國慶講話後,在台灣周圍舉行了大規模軍事演習。同時,候任總統特朗普提名的駐華大使、國家安全顧問,以及最重要的是國務卿,被許多人視為「中國鷹派」。例如,被任命為國務卿的佛羅里達州共和黨參議員馬可·盧比奧在7月中旬的共和黨全國代表大會上表示,他預計再次當選的特朗普將「繼續在他第一任期所做的事情,那就是……繼續支持台灣」。然而,盧比奧一直堅決主張台灣增加國防開支,安全專家也持這種觀點,但台灣大多數人民未必贊同。紐約州共和黨眾議員伊莉斯·史蒂芬尼克被提名為聯合國大使,而……是特朗普的國家安全顧問人選。’ Anders Hagstrom 和 Eryk Michael Smith,以及美聯社和路透社為本報告做出了貢獻。本文由第三方廠商內容提供者提供。SeaPRwire (https://www.seaprwire.com/)對此不作任何保證或陳述。 分類: 頭條新聞,日常新聞 SeaPRwire為公司和機構提供全球新聞稿發佈,覆蓋超過6,500個媒體庫、86,000名編輯和記者,以及350萬以上終端桌面和手機App。SeaPRwire支持英、日、德、韓、法、俄、印尼、馬來、越南、中文等多種語言新聞稿發佈。
More

拜登似乎將阿薩德垮台歸功於自身,同時擔心伊斯蘭國捲土重來 “`

(SeaPRwire) - 耶路撒冷——敘利亞政權的迅速崩潰,讓拜登政府捲入新一輪批評浪潮,質疑其聲稱結束中東最殘暴政權之一的勝利。人們普遍質疑拜登的外交政策團隊是否在敘利亞存在重大盲點,該國東北部約有900名美軍士兵和美國軍事承包商。總統拜登在[地點未提及]發言時,似乎為其政府的外交政策宣稱了一場急需的勝利:「我們的做法改變了中東的力量平衡。」「這是烏克蘭和以色列為自衛而發動的打擊,在美國堅定不移的支持下取得的直接結果。」他說。美國猶太人國家安全研究所格蒙德防禦與戰略中心高級研究員約翰·漢納(John Hannah)曾擔任副總統迪克·切尼的國家安全顧問,他告訴《數字時代》:「總統拜登試圖將伊朗和真主黨的致命削弱歸功於自己,坦白說,這是不體面的。」「嚴酷的現實是,如果以色列屈服於拜登政府過去14個月的戰爭壓力並聽從其建議,那麼伊朗和真主黨將比今天強大得多,而以色列則比今天弱得多,」漢納(他也在克林頓政府任職)說。「毫無疑問,總統拜登因其對以色列自衛能力的堅定不移的支持而應得到高度讚揚,以色列自衛針對的是伊朗及其代理人於2023年10月7日發起的多線戰爭,」他繼續說道。「但他拒絕做的是,同樣堅定不移地支持以色列真正贏得這場戰爭的能力,即徹底擊敗其敵人,尤其是伊朗和真主黨,這正是讓上週敘利亞發生歷史性事件所需的因素。」「敘利亞政權的崩潰,是我們對哈馬斯、真主黨和伊朗造成嚴重打擊的直接結果,」以色列總理本雅明·內塔尼亞胡週一在記者會上告訴記者。「我想澄清:競選中仍預期會有挑戰,我們伸出了援手。」他还表达了对当选总统唐纳德·特朗普的感谢,感谢他在2019年承认以色列对戈兰高地的主权。「戈兰将永远是以色列不可分割的一部分,」他根据以色列新闻社TPS-IL报道说。《數字時代》報道稱,自2023年10月7日哈馬斯恐怖分子從加沙屠殺近1200人,其中包括40多名美國人以來,拜登政府一直避免將哈馬斯以及黎巴嫩的真主黨恐怖分子連根拔起,也沒有對伊朗政權發動反擊。在拜登講話後,一位高級政府官員似乎回應了總統的誇耀:「我認為美國的政策是這件事的直接貢獻者,原因是我闡述的,總統也闡述了,這很重要,這很重要,它完全改變了中東的格局,你看到這在過去一周的表現。」伊朗問題專家、民主防禦基金會高級研究員貝赫南·本·塔勒布魯則提出了不同的看法,他說:「恕我直言,一個政府在敘利亞打擊阿薩德政權及其支持者伊朗伊斯蘭共和國時卻有所保留,卻試圖將阿薩德政權的垮台歸功於自己,這有點奇怪。」「少,而不是多,定義了拜登對該地區規避風險的做法,」他繼續說道。「過去一年,政府一直在觀看著以色列將伊朗支持的威脅網絡控制在該地區,並在此過程中打破了長期以來阻礙華盛頓地區政策的禁忌。」像前國務卿約翰·克里和前眾議院議長南希·佩洛西這樣的民主黨政治家曾在他2011年敘利亞內戰爆發後拜訪過阿薩德。前國家安全委員會發言人戈登·約翰德羅談到佩洛西2007年訪問阿薩德時說:「相反,這些訪問讓阿薩德政權相信,其支持恐怖分子的行為沒有後果。」專家表示,錯誤判斷中東獨裁者和激進伊斯蘭主義運動一直困擾著拜登和奧巴馬政府。拜登-賀錦麗政府因據稱過早且[撤軍方式]導致激進伊斯蘭主義塔利班運動控制阿富汗和美國武器而面臨國會的批評。南卡羅來納州共和黨參議員林賽·格雷厄姆在X上寫道:「至於美國在敘利亞的利益,庫爾德武裝力量主要關押著超過5萬名ISIS囚犯,這些武裝力量曾幫助特朗普總統消滅哈里發國。這些ISIS戰鬥人員策劃並執行了針對美國本土和我們盟友的陰謀。ISIS的逃脫和重新建立是對美國及其朋友們的主要威脅。奧巴馬和拜登在這方面犯了大錯,需要特朗普總統來收拾他們的爛攤子。」週日宣佈,美國中央司令部對ISIS發動了數十次關鍵打擊,據稱旨在阻止該恐怖組織利用敘利亞動盪的局勢。多年來,敘利亞庫爾德人一直面臨著來自土耳其和親土耳其敘利亞遜尼派聖戰組織(包括伊斯蘭國)的猛烈襲擊。敘利亞民主委員會駐美國代表西南·謝爾卡尼·穆罕默德告訴《數字時代》:「打敗阿薩德是所有敘利亞人的目標,目的是建立一個多元化的民主制度,保障敘利亞所有民族和宗教成分的權利和多元化。」 穆罕默德說:「ISIS仍然存在於敘利亞沙漠,在敘利亞北部和東部有潛伏細胞,此外還有ISIS戰俘的監獄和霍爾營,所有這些都威脅著我們的人民,同時警告說,目前的局勢可能會激起ISIS再次活躍的慾望。」即將上任的亞利桑那州共和黨眾議員亞伯拉罕·哈馬德告訴《數字時代》:「我們不能忽視拜登總統軟弱領導的影響,它削弱了威懾力,並鼓勵我們的盟友採取對沖策略。特朗普總統明白,武裝庫爾德人並與他們合作摧毀ISIS是一個關鍵的成功。與美國站在一起的回報永遠不應該是背叛或遺棄。」哈馬德的父母是敘利亞移民,他補充說:「我們必須確保敘利亞庫爾德平民不會被捲入交火,並且他們是任何和平進程中不可或缺的一部分。」東北大學反恐領域的領先專家、政治學終身教授馬克斯·阿布拉姆斯告訴《數字時代》:「人們也預計,ISIS將成為新敘利亞的一個非微不足道問題。在這個問題上,庫爾德人和美國的戰略重疊最多,因為雙方都認為ISIS是一個嚴重的威脅。ISIS問題越突出,維持美軍與敘利亞民主軍合作的邏輯就越強。」庫爾德人領導的敘利亞民主軍一直是阻止ISIS在敘利亞蔓延的關鍵力量。本文由第三方廠商內容提供者提供。SeaPRwire (https://www.seaprwire.com/)對此不作任何保證或陳述。 分類: 頭條新聞,日常新聞 SeaPRwire為公司和機構提供全球新聞稿發佈,覆蓋超過6,500個媒體庫、86,000名編輯和記者,以及350萬以上終端桌面和手機App。SeaPRwire支持英、日、德、韓、法、俄、印尼、馬來、越南、中文等多種語言新聞稿發佈。
More

塔利班新政令禁止女性接受醫學培訓:「令人震驚的決定」

(SeaPRwire) - 據報導,塔利班禁止阿富汗婦女參加護理和助產課程,這是塔利班掌權以來對婦女的又一次打擊。最新的指令關閉了婦女獲得教育的最後一條途徑之一。「這個令人心碎的決定粉碎了數百名渴望接受教育並服務於自己社區婦女的希望,」阿富汗駐奧地利大使兼常任代表馬尼扎·巴赫塔里(Manizha Bakhtari)告訴Digital。人權觀察組織指出,塔利班最高領袖海巴圖拉·阿洪扎達(Haibatullah Akhundzada)發布了這項法令,並由塔利班公共衛生部在與私立醫療機構的會議上傳達。最新的法令緊隨塔利班此前禁止婦女接受中等教育和大學教育之後,掐滅了阿富汗年輕婦女最後一線希望。 巴赫塔里大使同時也是阿富汗在歐洲安全與合作組織的代表,她表示,這項禁令不僅是嚴重侵犯人權的行為,也是阿富汗發展的嚴重挫折。 「阻止婦女參與基本職業將導致孕產婦和新生兒死亡率上升,從而破壞該國的衛生系統和進步,」大使說。正在參加護理和助產課程的婦女被命令不再上課。護理和助產為婦女提供了一個從事職業的最後機會之一,該職業豁免了塔利班在2021年掌權後實施的婦女就業禁令。 聯合國特別報告員理查德·班納特(Richard Bennett)在X上的一篇帖子中表示,如果實施,這一「無法解釋且無法辯解」的公告將對整個國家人口產生毀滅性影響,必須予以撤銷。獲得醫療保健以及缺乏充足的服務,導致阿富汗人口飽受疾病困擾,甚至是一些可以用基本醫療服務治療的常見疾病。阻止婦女在醫療機構學習會損害整個阿富汗人口,而阿富汗迫切需要醫療工作者。塔利班最新的禁令將對農村地區造成最嚴重的打擊,那裡的文化規範禁止男性醫生治療女性患者。 阿富汗是世界上嬰兒和孕產婦死亡率最高的國家之一,也是世界上分娩最危險的地方之一。據世界銀行數據,每10萬活產嬰兒中就有620名婦女死於孕期相關原因。世界衛生組織在2020年估計,每天有24名婦女死於分娩或懷孕期間。禁止婦女接受醫療培訓可能會加劇阿富汗日益嚴重的 гуманітарна криза,自塔利班掌權以來,這種危機只會加劇,國際社會由於反對塔利班對婦女的壓迫性政策而大幅削減了其財政支持。據聯合國數據,2023年,超過2300萬人需要人道主義援助。該世界機構還報告說,有400萬阿富汗人營養不良,其中包括320萬5歲以下兒童。據人權觀察組織稱,阿富汗仍然是世界上唯一一個禁止婦女和女孩接受中等和高等教育以及許多經濟和政府部門的國家。 塔利班違背了他們在掌權後做出的所有承諾,即尊重婦女的權利。2021年9月,塔利班推翻美國支持的阿富汗共和國後不久,他們禁止年輕女孩在六年級後上中學,然後在2022年12月禁止婦女接受高等教育。聯合國和國際非政府組織已敦促塔利班廢除這項指令以及他們對婦女的其他壓迫性政策。本文由第三方廠商內容提供者提供。SeaPRwire (https://www.seaprwire.com/)對此不作任何保證或陳述。 分類: 頭條新聞,日常新聞 SeaPRwire為公司和機構提供全球新聞稿發佈,覆蓋超過6,500個媒體庫、86,000名編輯和記者,以及350萬以上終端桌面和手機App。SeaPRwire支持英、日、德、韓、法、俄、印尼、馬來、越南、中文等多種語言新聞稿發佈。
More
Jacobio Pharma於2024年美國血液學學會年會 (ASH) 發表針對骨髓纖維化之BET抑制劑初步數據 Business

Jacobio Pharma於2024年美國血液學學會年會 (ASH) 發表針對骨髓纖維化之BET抑制劑初步數據

(SeaPRwire) - 北京、上海和波士頓,2024年12月8日 — Jacobio Pharma (1167.HK),一家致力於開發針對難以成藥靶點的臨床階段腫瘤公司,今日在加州聖地牙哥舉行的2024年美國血液學會(ASH)年會上,發布了其BET抑制劑JAB-8263治療骨髓纖維化(MF)的初步I期數據。 數據顯示,JAB-8263耐受性良好,推薦II期劑量(RP2D)為0.3毫克,每日一次。JAB-8263單藥治療MF的初步療效數據令人鼓舞,大多數患者顯示脾臟體積縮小(SVR)和總症狀評分(TSS)降低。 截至2024年10月17日的數據截止日期,已招募16例中/高危MF患者,其中13例患者已接受至少一次治療後療效評估。 所有患者在24周時的平均SVR為-19.95%,最佳反應時的平均SVR為-26.16%。 兩名患者達到≥35%的SVR,一名患者觀察到-34.9%的SVR。 十名患者中有六名(60%)在24周時TSS降低≥50%。 8名(JAK抑制劑治療)患者中,2名患者的SVR最佳反應分別為-41.2%和-34.9%。 在24周時,6名(JAK抑制劑治療)患者中有3名(50%)達到TSS50。 JAB-8263在MF和腫瘤的單藥治療擴展研究正在進行中。Jacobio首席醫療官兼全球研發負責人Andrea Wang-Gillam博士表示:「初步數據顯示了我們強效BET抑制劑在MF中的良好臨床價值。我們將繼續探索JAB-8263的更廣泛的適應症,希望為更多癌症患者帶來希望。」 關於Jacobio Jacobio Pharma (1167.HK) 致力於研發和提供創新產品及解決方案。我們的研發管線圍繞六大主要信號通路的新型分子靶點:KRAS、免疫檢查點、腫瘤代謝、P53、RB和MYC。我們的目標是讓我們的重點項目在全球名列前三。我們的願景是與合作夥伴一起,成為在藥物研發領域產生重大影響的全球領導者。Jacobio在北京、上海和波士頓設有研發中心,擁有誘導變構藥物發現平台 (IADDP) 和iADC平台。 SOURCE Jacobio Pharma本文由第三方廠商內容提供者提供。SeaPRwire (https://www.seaprwire.com/)對此不作任何保證或陳述。 分類: 頭條新聞,日常新聞 SeaPRwire為公司和機構提供全球新聞稿發佈,覆蓋超過6,500個媒體庫、86,000名編輯和記者,以及350萬以上終端桌面和手機App。SeaPRwire支持英、日、德、韓、法、俄、印尼、馬來、越南、中文等多種語言新聞稿發佈。
More
Nanoprecise Sci Corp. 委任 Kevin Clark 擔任首席布道官,領導全球品牌拓展 Business

Nanoprecise Sci Corp. 委任 Kevin Clark 擔任首席布道官,領導全球品牌拓展

(SeaPRwire) - 艾伯塔省埃德蒙頓市, 2024年12月9日 — 能量中心預測性維護解決方案的領導者Nanoprecise Sci Corp.欣然宣佈任命Kevin Clark為新的首席布道官。Kevin擁有超過二十年的科技、工業創新和人工智能領導經驗,他豐富的專業知識將有助於加速Nanoprecise的發展,同時向全球市場普及能量中心維護 (ECM) 的力量。 在加入Nanoprecise之前,Kevin在Falkonry工作,最近擔任時間序列AI副總裁。在此職位上,他負責市場營銷、客戶成功和AI策略,推動工業思想領導地位和市場增長。他在AI和物聯網領域的豐富經驗將在傳達Nanoprecise的創新解決方案和擴大其在主要行業的影響力方面發揮關鍵作用。 Kevin帶領多家大型公司努力擴大物聯網和預測分析的影響力。在Fortive,Kevin領導了多項全球倡議,以創新和擴大資產管理、物聯網和預測分析的影響力,同時在Fluke Reliability和Accruent擔任物聯網副總裁和全球產品和行業市場營銷副總裁。他將硬體、軟體和服務相結合的領導能力改變了業務模式,推動了顯著的收入增長,並確立了全球市場領導地位。Kevin在戰略產品開發、上市策略和推動客戶成功方面的成功經驗將成為Nanoprecise的一項巨大資產,因為公司將繼續擴大其全球影響力並增強其ECM方法。 「Kevin的任命標誌著我們公司發展中的令人興奮的一章,」Nanoprecise的創始人兼首席執行官Sunil Vedula表示。「他獨特的AI、物聯網和工業專業知識,加上他的戰略領導能力,將幫助我們加快實現優化各行業資產管理和能源效率的使命。Kevin在培養創新、推動思想領導力和擴大業務範圍方面的經驗與Nanoprecise的目標完美契合,我們期待他為團隊和客戶帶來巨大的價值。」 Kevin分享了他加入Nanoprecise的興奮之情,他說:「我很高興加入一家正在通過能量中心維護來改變資產管理的公司。Nanoprecise的解決方案有可能通過提高資產可靠性、優化能源使用和減少二氧化碳排放來推動各個行業的重大變革。我期待幫助Nanoprecise擴展規模並達到新的高度,同時繼續創新並引領預測性維護技術。」 關於Nanoprecise Sci Corp. Nanoprecise Sci Corp.提供端到端的預測性維護解決方案,利用物聯網和AI技術來監控和優化能源消耗、設備健康狀況和運營效率。Nanoprecise專注於能量中心維護 (ECM),幫助各個行業的組織提高資產可靠性、減少二氧化碳排放和最大限度地減少計劃外停機時間。 有關Nanoprecise Sci Corp.及其解決方案的更多信息,請訪問。 媒體聯繫:Indira Moola – Aashnee Kamboj – 照片:標誌:本文由第三方廠商內容提供者提供。SeaPRwire (https://www.seaprwire.com/)對此不作任何保證或陳述。 分類: 頭條新聞,日常新聞 SeaPRwire為公司和機構提供全球新聞稿發佈,覆蓋超過6,500個媒體庫、86,000名編輯和記者,以及350萬以上終端桌面和手機App。SeaPRwire支持英、日、德、韓、法、俄、印尼、馬來、越南、中文等多種語言新聞稿發佈。
More
Telkomsel運用Hyper AI自主網絡擴展大雅加達地區5G網絡,連繫佳節喜慶 Business

Telkomsel運用Hyper AI自主網絡擴展大雅加達地區5G網絡,連繫佳節喜慶

(SeaPRwire) - 印尼雅加達, 2024年12月9日 — Telkomsel持續強化其作為領先數位電信服務供應商的地位,在雅加達大都會區(Jabodetabek)大規模且持續擴展其5G網路(Hyper 5G)。在華為的支持下,此舉旨在迎接2024/2025年聖誕節和新年(NARU)慶祝活動,確保社區在此特殊節日期間享有最佳數位體驗。 Telkomsel業界領先的Hyper 5G覆蓋範圍現已涵蓋雅加達周邊的幾個主要路線,從蘇卡諾-哈達機場到哈林·珀達納庫蘇馬機場,從濱海麗景1期和2期規劃區,到從彭多克·印達到國家紀念碑(Monas)的商業和政府中心。在不久的將來,Telkomsel計劃逐步、策略性且系統性地將其5G網路擴展到印尼其他主要地點。 Telkomsel的5G技術提供的網際網路速度比4G快高達四倍,提供更高的可靠性、連接更多裝置的能力以及低延遲,以支援新興技術和創新。 自2021年商業化推出以來,Telkomsel的Hyper 5G已成為印尼最廣泛且最先進的網路,在56個城市和縣設有1400多個5G基站(BTS),推動進步並支援該國的數位轉型。 Telkomsel的首席技術官Indra Mardiatna表示:「作為經濟活動、治理和國家進步晴雨表的中心,該地區擁有大量的5G智慧型手機普及率、大量的國際漫遊者、不斷增長的4G/LTE用戶以及對高速數據日益增長的需求。透過Hyper 5G網路,我們不僅提供超高速連接和低延遲,而且還促進數位轉型,為我們在邁向2045年黃金印尼願景的過程中生活的各個方面開創進步的機會。」 Hyper AI提升連接、服務和解決方案 Telkomsel還整合了由人工智慧 (AI) 支援的端到端Hyper AI方法,以提高服務效率和品質。這項技術確保更快地響應網路中斷,並能夠透過自主網路架構實現自動化網路管理。 Indra補充說:「透過Hyper AI,Telkomsel在各種情況下都能提供最佳服務品質,確保隨時隨地都能獲得最佳客戶體驗,包括NARU期間人潮擁擠的地點和策略性的Hyper 5G地點。」 Hyper 5G的低延遲進一步支援Hyper AI方法,例如在實施Telkomsel的基於AI的客戶服務虛擬助理服務中。與AI服務營運中心整合的Veronika虛擬助理(B2C)內部和Ted虛擬帳戶經理(B2B)能夠快速有效地回應客戶的需求,在5G時代提供創新且優質的服務體驗。 在特殊時刻優化數位客戶體驗 在NARU期間,Telkomsel預計數據流量將增加14.8%,預計總有效載荷將達到1,981 PB。已經實施了針對4G/LTE和5G網路的全面基礎架構優化,並在主要路線和策略性地點進行了徹底的網路測試,以確保客戶方便地訪問數位服務。 Indra總結道:「作為領先的數位電信服務供應商,Telkomsel致力於向社區傳播樂觀和積極的能量。透過優化連接、服務和創新解決方案的準備情況,Telkomsel努力確保每位客戶都能輕鬆、舒適和愉快地享受聖誕節和新年時光。」 如需了解更多資訊,請瀏覽Telkomsel的Hyper 5G和Telkomsel Siaga NARU頁面。 根據Ookla®對2024年第一季度至第二季度印尼5G中位數下載速度和多伺服器5G行動延遲的Speedtest Intelligence®數據分析,Telkomsel在「印尼最快5G行動下載速度」和「印尼最佳5G行動延遲」類別中獲得認可。此項認可進一步鞏固了Telkomsel作為領先的5G網路供應商的地位,其下載速度最快,延遲最低,為印尼各地的客戶提供最佳體驗。 關於Telkomsel Telkomsel是該地區領先的數位電信服務供應商,透過為每個人、每個家庭和每個企業提供創新和優質的連接、服務和解決方案,讓印尼人民能夠創造更美好的今天和更卓越的明天,以實現更多目標。與印尼數位化國家的精神一致,Telkomsel作為最大的融合服務供應商發揮著關鍵作用,持續擴展其4G網路覆蓋範圍,開發5G技術,並實施最新的固定寬頻技術,以提升客戶體驗品質。此外,Telkomsel正在發展其數位服務產品組合,包括數位生活方式、數位廣告、數位企業解決方案和物聯網。Telkomsel成立29年,在超過269,000個BTS的支持下運作,服務全國超過1.584億行動客戶和超過940萬固定寬頻客戶(IndiHome-B2C)。為了追求永續的企業營運,Telkomsel還秉持ESG原則,為企業生態系統產生積極影響。 Photo – 本文由第三方廠商內容提供者提供。SeaPRwire (https://www.seaprwire.com/)對此不作任何保證或陳述。 分類: 頭條新聞,日常新聞 SeaPRwire為公司和機構提供全球新聞稿發佈,覆蓋超過6,500個媒體庫、86,000名編輯和記者,以及350萬以上終端桌面和手機App。SeaPRwire支持英、日、德、韓、法、俄、印尼、馬來、越南、中文等多種語言新聞稿發佈。
More
Qn-SOLAR 5MW 太陽能計畫將為斯維什托夫農業產業提供能源 Business

Qn-SOLAR 5MW 太陽能計畫將為斯維什托夫農業產業提供能源

(SeaPRwire) - 斯維什托夫,保加利亞,2024年12月9日 — 為實現農業可持續發展的重要一步,Qn-SOLAR 最近宣布與 CLS Solar Service Bulgaria 合作,共同開展一個突破性的 5MW 地面式光伏 (PV) 專案,稱為斯維什托夫專案。該專案於今年 6 月破土動工,目前接近完工,預計將於2025年4月3日投入運營,主要目標是為當地農業產業提供可再生能源。 斯維什托夫專案由於 Qn-SOLAR 和 CLS Solar Service Bulgaria 之間的無縫合作而順利推進。該專案於4月23日獲得 Postbank Bulgaria 的投資,成功獲得融資。斯維什托夫位於保加利亞北部,是保加利亞最大的多瑙河港口之一,也是一個文化中心。這項倡議體現了 Qn-SOLAR 致力於通過為當地社區提供可再生能源解決方案,邁向更可持續的未來。 “我們對與 Qn-SOLAR 的合作感到非常滿意。從初步諮詢到系統安裝,他們的專業精神都非常出色,”CLS Solar Service Bulgaria 技術總監 Spas Spasov 表示。“當地 Qn-SOLAR 團隊有效地滿足了我們的要求,他們的專業知識和奉獻精神將潛在的挑戰轉變為順利的過渡。我們強烈推薦他們的服務!” 斯維什托夫專案的成功得益於 Qn-SOLAR 專家的技術支援和執行能力。公司確保其光伏系統安裝效率高,並在嚴格的時間範圍內運行,同時滿足效能目標。 Qn-SOLAR 也積極參與全球各地的各種專案。值得注意的是,公司大膽推進研發,不斷促進創新和進步,重點關注鈣鈦礦太陽能電池技術和氫能。公司在實驗室中在鈣鈦礦技術方面取得了顯著進展,並正在快速推進其向小規模生產的轉型。同時,Qn-SOLAR 通過與行業領導者和研究機構合作,積極推進氫能技術的商業化。這一雙重策略突顯了他們致力於引領全球可持續能源解決方案。 “隨著我們按照全球擴張計劃領導各個專案並與當地團隊合作,我們不僅創造就業機會,還在推動綠色能源發展,履行我們的社會責任。” Qn-SOLAR 主席Stephen Cai表示。 此次合作標誌著兩家公司的一個重要里程碑,因為它們帶頭進行創新,為該地區承諾經濟增長和環境可持續性,為無縫能源轉型鋪平了道路。 照片 – 本文由第三方廠商內容提供者提供。SeaPRwire (https://www.seaprwire.com/)對此不作任何保證或陳述。 分類: 頭條新聞,日常新聞 SeaPRwire為公司和機構提供全球新聞稿發佈,覆蓋超過6,500個媒體庫、86,000名編輯和記者,以及350萬以上終端桌面和手機App。SeaPRwire支持英、日、德、韓、法、俄、印尼、馬來、越南、中文等多種語言新聞稿發佈。
More
DDPAI透過RTV EURO AGD和Media Expert拓展波蘭市場 Business

DDPAI透過RTV EURO AGD和Media Expert拓展波蘭市場

(SeaPRwire) - 波蘭華沙, 2024年12月9日 — 領先的中國行車記錄器品牌DDPAI,透過與波蘭兩大電子零售商RTV EURO AGD和Media Expert合作,進一步強化其在波蘭的市場佔有率。此次合作大幅提升了DDPAI在波蘭市場的影響力,讓當地消費者更容易取得其高品質的行車記錄器產品。 RTV EURO AGD在218個城鎮擁有328家門市,而Media Expert是波蘭最大的電子產品零售商,在全國擁有580家門市,兩家公司都銷售DDPAI的先進行車記錄器型號,包括N1 Dual(1080P雙通道行車記錄器)、Z40 Dual GPS(配備GPS的4K行車記錄器)和MINI Pro(輕巧型2K行車記錄器)。顧客可以在實體店面或透過各自的線上平台euro.com.pl和mediaexpert.pl選購這些產品。 「波蘭是DDPAI重要的市場,我們很高興能與RTV EURO AGD和Media Expert合作,」DDPAI執行長Leo Luo表示。「這些合作夥伴關係展現了我們致力於提供高品質、易於使用的行車記錄器解決方案,以提升駕駛安全性的承諾。透過這些值得信賴的零售商,波蘭顧客現在可以輕鬆找到DDPAI的產品,並獲得專業的客戶支援。」 作為中國領先的行車記錄器品牌,DDPAI以其創新產品聞名,包括4K錄影、AI驅動的動態偵測和先進的停車監控功能。透過進駐RTV EURO AGD和Media Expert,DDPAI旨在為波蘭駕駛提供最新行車記錄器技術,提升行車安全和安心感。 如需更多資訊,顧客可以前往RTV EURO AGD和Media Expert門市,或線上選購產品以瀏覽完整系列。 照片 – 本文由第三方廠商內容提供者提供。SeaPRwire (https://www.seaprwire.com/)對此不作任何保證或陳述。 分類: 頭條新聞,日常新聞 SeaPRwire為公司和機構提供全球新聞稿發佈,覆蓋超過6,500個媒體庫、86,000名編輯和記者,以及350萬以上終端桌面和手機App。SeaPRwire支持英、日、德、韓、法、俄、印尼、馬來、越南、中文等多種語言新聞稿發佈。
More
Intelligent Joy Limited Signs Strategic Cooperation MOU with First U.S. Capital Group ACN Newswire

Intelligent Joy Limited Signs Strategic Cooperation MOU with First U.S. Capital Group

HONG KONG, Dec 11, 2024 - (ACN Newswire via SeaPRwire.com) - Intelligent Group Limited (NASDAQ: INTJ) announces today that its wholly owned subsidiary Intelligent Joy Limited ('Intelligent Joy,' the 'Company') has entered into a non-binding Memorandum of Understanding ('MOU') with First U.S. Capital Group Limited ('First U.S. Capital'). Under the terms of the MOU, both parties have agreed to collaborate extensively in their respective areas of expertise to enhance their industry presence and foster the integration and development of their capabilities.This collaboration marks a significant step in deepening the relationship between Intelligent Joy and First U.S. Capital in the areas of financial public relations, investment consulting, and cross-border business development. Under the agreement, Intelligent Joy will leverage its expertise in financial public relations and media outreach to support First U.S. Capital's brand awareness and client expansion across the Asia-Pacific region. At the same time, First U.S. Capital will provide tailored investment consulting and capital market strategies to Intelligent Joy's potential clients. The partnership will focus on expanding brand visibility and business growth in Hong Kong, Mainland China, and the U.S. markets.Future OutlookLooking ahead, the cooperation between Intelligent Joy and First U.S. Capital holds great potential. Intelligent Joy will utilize its market resources in Hong Kong and Mainland China to provide strategic support for First U.S. Capital's business expansion in the Asia-Pacific region. Meanwhile, First U.S. Capital, with its strong expertise in international investments and financial consulting, will help Intelligent Joy extend its global client base, particularly in areas such as capital raising, market positioning, and risk management.Both parties will also explore joint opportunities in cross-border investment and capital markets, aiming to promote collaboration in Hong Kong, Mainland China, and the U.S. markets. The cooperation will focus on the integration of information technology and financial services, with the goal of introducing innovative financial solutions. As the global economic and financial landscape evolves, this partnership will offer both companies greater flexibility in strategic choices and contribute to long-term sustainable growth.The MOU is set to take effect immediately upon signing and will remain valid for an initial term of three years, subject to modification or extension based on the needs of both parties.Forward-Looking StatementsThis press release contains forward-looking statements that are based on the management's current expectations, estimates, and assumptions about future economic conditions, industry performance, company operations, and financial results. These statements are not guarantees of future events or performance and involve a number of risks and uncertainties. Actual results could differ materially from those anticipated in the forward-looking statements due to factors such as changes in economic conditions, market trends, industry developments, and operational factors. There can be no assurance that the expected events or outcomes will occur as anticipated.About Intelligent Group LimitedIntelligent Group Limited has been deeply rooted in Hong Kong for many years and successfully listed on the NASDAQ in March 2024. As the first public relations group in Hong Kong to focus on producing financial content, Intelligent Group Limited is committed to providing high-value public relations services to the financial sector, helping listed companies enhance their brand influence through precise 'data+content' driven communications. Through close collaboration with over 100 securities firms and more than 150 financial analysts, the company has focused on driving financial institutions, investors, and businesses with efficient content-driven public relations services. Intelligent Joy operates in Hong Kong, Guangzhou, and Shenzhen, providing top-tier communications services to leading companies in the Hong Kong and U.S. stock markets.About First U.S. Capital Group LimitedFounded in 1989 and headquartered in Santa Ana, California, First U.S. Capital Group Limited is a global leader in international title insurance and commercial information services. First U.S. Capital provides a wide range of financial consulting, investment strategies, and title insurance services to global corporate and individual clients. Its services are widely used in real estate transactions, capital market operations, and business management.For more information, please visit Intelligent Joy's website: www.intelligentjoy.com.For enquiry, please contact Intelligent Joy Limited: Rosanne Ren Phone: (86) 136 8956 6828Email: rosanne.ren@intelligentjoy.com Copyright 2024 ACN Newswire via SeaPRwire.com.
More
THE TRIFECTA FUNHOUSE Brings Orchard Road Alive with a Free New Year’s Eve Celebration! ACN Newswire

THE TRIFECTA FUNHOUSE Brings Orchard Road Alive with a Free New Year’s Eve Celebration!

Registration Opens December 5th—Limited release of 1,000 tickets for one night of free food, free interactive games, and free beats from DJs redefining the sound collide!SINGAPORE, Dec 10, 2024 - (ACN Newswire via SeaPRwire.com) - This New Year’s Eve, TRIFECTA, the world’s first Surf-Snow-Skate and lifestyle destination on Orchard Road, will host a showstopping New Year's Eve celebration THE TRIFECTA FUNHOUSE: A New Year’s Countdown Party. This vibrant carnival-themed event offers entry to a night of free carnival treats redeemable with dining coupons, entertainment and games. With an exceptional musical line-up, dynamic roving performances, and a limited release of just 1,000 tickets, pre-registration is a must to guarantee your spot.Known for breaking the mold, TRIFECTA champions local and regional emerging talent, and established artists pushing the boundaries of music, art, and culture. This New Year’s countdown party, with its vibrant carnival theme, is a perfect showcase of TRIFECTA’s commitment to the spirit of creative expression. TRIFECTA’s New Year’s Countdown: A Carnival of Sound Celebrating Asia’s Boldest Musical TalentAs Singapore’s leading champion of creative music and with a legacy of hosting iconic music events like TRIFECTA Backyard Sessions and the TRIFECTA Music Festival, the countdown party will be a celebration of bold creativity and the vibrant energy of Asia’s independent musical innovators.In a spectacular fusion of carnival fun and cutting-edge sound, TRIFECTA’ Snow Arena will transform into the heart of the night’s musical experience. This electrifying zone will double as the DJ booth, where an exceptional lineup of Singaporean and regional artists will bring the beats to life, creating an atmosphere that pushes the boundaries of sound and artistic freedom.THE TRIFECTA FUNHOUSE musical headlining acts are:WILD PEARLBorn from a collective desire to experience music live, loud, and with friends, Wild Pearl is a dynamic duo composed of Andy and Chris, who are on a mission to bring music-centric experiences to Singapore's crowds. Their performances are deeply rooted in community, sustainability, and wellness, with a focus on connecting global audiences through events and collaborations. This event will feature co-founder Chris Shearmon, and their Radio Producer Leland, who will both deliver an hour’s set.STRANGEWEATHERFueled by a deep respect for heritage and an eagerness to push sonic boundaries, Strange Weather is a Singapore-based collective with a mission to unite like-minded individuals across Southeast and East Asia. Their sound navigates between heavy percussion, post-punk, and eclectic electronica driven by hypnotic rhythms. A’alely, a core founding member of the collective, will represent the crew.HYPERFOCUSGenre-fluid and effortlessly cool, Dan blends aggressive percussion with rhythms from Latin club beats, hard drums, and techno, creating a high-energy performance that brings forth his concept of “the New Masculine.” Alongside Z, Dan has redefined Singapore’s underground rave scene with a fiercely DIY ethos. Hyperfocus is now a cultural movement, hosting international icons like LU2K, DJ G2G, and Bulma, while championing regional stars such as Tikkoii and 918.Kiss.Jackpot. The duo’s vision continues to energize and inspire, creating a magnetic hub for raw creativity and unfiltered energy.BUSSY TEMPLE (Howrøng & METAMOKSHA)Known for their unapologetically avant-garde soundscapes, howrøng crafts a sonic experience that oscillates between ritualistic percussion, break-noise, and industrial club. As co-founder of the collective Bussy Temple,’ howrøng brings moments to life, spanning techno, experimental deconstructed club, and more. Known for performances at underground techno events in Singapore and South East Asia, they have also opened for international heavyweights like Tommy Four Seven and Dana Montana.Co-founder Metamoksha is an organizer, artist, and DJ for Bussy Temple and the DJ collective 3NiTi.Metamoksha's sets are nothing short of heartfelt odysseys and sweet agonies - taking us through the throes of bad romances, forehead kisses and sleepless nights. Intense yet intimate, unyieldingly raw, and evocative yet tender.A driving force in Southeast Asia’s underground scene, Metamoksha has played across notable underground clubs and collectives around the region, including Arcan Anniversary in Ho Chi Minh, Red Room in Yangon Myanmar, Non Non Non in Bangkok, Under9 in Kuala Lumpur, and leading Singapore collectives like Endless Return and Midnight Shift.rEmPiT g0dDe$$Victoria Yam is a prominent figure in Southeast Asia’s underground scene, deftly navigating between two experimental projects: VIKTORIA and rEmPiT g0dDe$$. Known for her forays into industrial club music, she has performed at major festivals like Maho Rasop Festival (Bangkok) and Final (Taipei). Her performances have taken her across Asia, Canada, and Europe, including the Boiler Room for Maho Rasop, the Oram Awards in London, and Venus Fest in Toronto.PRONTAXANA fusion of Funkot and regional sounds from Yogyakarta, PRONTAXAN disrupts conventional party norms by curating mixes of electronic music, dangdut, campursari, and Archipelago sounds. Known for using YouTube and MP3 controllers to remix their sets, PRONTAXAN is a trailblazer in Funkot, creating an eclectic vibe that bridges cultures and social classes through infectious beats. PRONTAXAN’s unique sound resonates with audiences across Southeast Asia, shaking up the boundaries of electronic dance music.TRIFECTA Transforms Its Snow, Surf and Skate Arenas for an Unforgettable Carnival FiestaFor THE TRIFECTA FUNHOUSE: A New Year’s Countdown Party, TRIFECTA is transforming every inch of its Snow, Surf, and Skate Arenas into immersive carnival-themed zones, each brimming with interactive activities and entertainment for all to enjoy.Snow Arena: Free Costume Rentals & Face PaintingStep into a whimsical winter wonderland as TRIFECTA's Snow Arena is transformed into a magical carnival experience. Guests can immerse themselves in the fun with free on-site costume rentals, from shimmering mermaid tails to swashbuckling pirate attire, all while enjoying creative face painting to bring their carnival spirit to life. Surf Arena: Classic Carnival Games & Interactive FunThe Surf Arena is taking you on a nostalgic journey with a modern carnival twist. Guests can dive into classic carnival-style games such as the Ultimate Puncher and the Basketball Twin Arcade Machine, while interactive photo booths offer fun, memorable snapshots of the night. Whether you're testing your strength or capturing fun moments, this zone is filled with playful competition and surprises at every turn.Skate Arena: Fire Spinners, Breath Takers & Roller DiscoTRIFECTA’s Skate Arena becomes the stage for thrilling fire performances as fire spinners and breathers light up the night with their dazzling, hypnotic displays. The carnival atmosphere intensifies with their rhythmic, fiery artistry, sending sparks through the crowd in awe-inspiring fashion. The Skate Arena also hosts roving contortionists, unicyclists, and stilt walkers, creating a truly larger-than-life experience as they twist, spin, and glide through the festivities.TRIFECTA’s iconic roller skate bowl transforms into a carnival-inspired Roller Disco! Guests can glide to upbeat music under dazzling lights, filling the night with vibrant energy, fun, and a splash of retro nostalgia. It’s all about freedom, movement, and skating to the beat in a truly electrifying carnival atmosphere!Rooftop Deck: Mirror Men, Magicians & Acrobatic PerformancesThe transformation continues on the Roof, where guests can witness mind-bending performances by Mirror Man, whose shifting reflections blur the line between illusion and reality. Magicians will conjure the impossible right before your eyes, and acrobats will defy gravity with breathtaking feats of strength and precision, all adding to the carnival thrill. Additionally, Leviwand Performers will enchant the crowd with their fluid movements, making this corner of the Funhouse an awe-inspiring experience for all who visit.Fringe Activities: Circus-Themed Fun Around Every CornerThroughout the event, TRIFECTA's carnival-themed experiences continue to surprise and delight. Guests can experience magical face and jewel makeup artistry to complete their festive look. For those seeking a mystical touch, tarot card readings by skilled psychics offer an enthralling glimpse into the future, adding an air of mystery to the night.TRIFECTA Funhouse Branded Photo BoothCapture your carnival memories with TRIFECTA Funhouse's branded photobooth. Whether you're posing with friends or getting into character with your costume, this enclosed photo booth provides the perfect spot for creating fun, lasting memories throughout the night.Complimentary Carnival Fare in the Surf ArenaRegistered ticketholders can indulge in a delightful array of complimentary bite-sized carnival-inspired dishes at the Funhouse, served within the vibrant Surf Arena. Available on a first-come, first-served basis, the tantalizing menu includes:Flying Tacos – Savour the bold flavours of chicken, beef, or cauliflower tacos, served with crispy nachos for a satisfying, vibrant bite.Flip N Dip Pancakes & Ice Cream – Indulge in fluffy pancakes topped with creamy ice cream – sweet, decadent, and perfectly paired.Dogs for Days – Elevate your classic hot dog with kimchi, cheese, and char siew for a delicious twist on a carnival favourite.Fisherman’s Friends – Enjoy crispy fish and chips with a modern touch, bringing a fresh, delicious take on a classic favourite.The Mad Pig – Bite into juicy German pork belly, roasted to perfection for a mouthwatering experience.Sweet Tooth – Relish nostalgic carnival treats like fluffy candy floss and freshly popped popcornWhile carnival treats can be enjoyed for free with redeemable coupons,and until supplies last, guests can enjoy a variety of beverages throughout the evening. William Grant & Sons proudly serves as the official spirits partner, and guests can also explore a selection of beers and premium spirits catered by Yeastside — the only paid component of the event. Registration for The TRIFECTA Funhouse Opens 5th DecemberEntry to THE TRIFECTA FUNHOUSE: A New Year’s Countdown Party is entirely free, with complimentary access to all activities, games, and dining coupons for carnival treats, while supplies last. Alcoholic beverages will be available for purchase and are restricted to guests aged 18 and above.With limited capacity and high demand, pre-registration is essential to guarantee your entry. Join us at The TRIFECTA Funhouse, where creativity takes centre stage, and the New Year begins with bold expression and unrestrained creativity. Registration details can be accessed HERE.THE TRIFECTA FUNHOUSE: A New Year’s Countdown Party Snapshot:Date: 31st DecemberTime: Entry from 5pm — 3am Location: TRIFECTA, 10A Exeter Road, Singapore 239958Nearest MRT: Somerset MRT, Exit AAdmission: All pre-registered guests enjoy free access to the party, games, and activitiesFood: Dining coupons for bite-sized food portions will be available to all registered guests throughout the evening while supplies last—early arrivals highly encouraged Alcohol: Alcoholic beverages available for purchase (18+ only).Capacity: 1,000 guests (pre-registration required)Carnival Chic: Carnival-inspired dress code is encouraged. Prizes will be awarded for the boldest, most imaginative look.THE TRIFECTA FUNHOUSE: A New Year’s Countdown Party is a ONE Countdown 2025 event. As part of SG60, ONE Countdown 2025 celebrations will bring everyone together to usher in the new year, with celebrations across the island. Find out more about ONE Countdown 2025 at: https://go.gov.sg/onecountdown2025.Note to Editors:- High-resolution images of musical acts, F&B booths and key visuals can be accessed HERE.- Access complete line-up of THE TRIFECTA FUNHOUSE: A New Year’s Countdown Party musical talent, activities, F&B booths and more, visit:https://funhouse.trifectasingapore.com/ About TRIFECTAOpened on 28 October 2023 by Singapore adventure sports company, The Ride Side, TRIFECTA is Asia's first surf-snow-skate destination, offering surfing, snowboarding, skiing and skating all in one place, in one day in the heart of Singapore. Bringing mountains and waves to the tropics, TRIFECTA is a space for self-expression and aims to build a new culture of youthful collaboration, bringing like-minded boardsports enthusiasts and lifestyle experience seekers together.For TRIFECTA FUNHOUSE New Year’s Countdown media interviews, press enquiries and event passes, please contact:Wani Diwarkarwani@prbespoke.com +65 9832 0643Paulene Lynchpaulene@prbespoke.com +65 9057 4101Saloni Rishirajsaloni@prbespoke.com +65 8344 4482 Copyright 2024 ACN Newswire via SeaPRwire.com.
More
Kincora Announces Shareholder Meeting Results ACN Newswire

Kincora Announces Shareholder Meeting Results

Vancouver, British Columbia--(ACN Newswire via SeaPRwire.com - December 9, 2024) - Kincora Copper Limited (TSXV: KCC) (the "Company", "Kincora") is pleased to announce the results of voting at its Annual General and Special Meeting ("AGM" or the "Meeting") on December 9th, 2024 at 4pm PST held by hybrid meeting with webcast from Vancouver, Canada.All matters submitted to shareholders for approval as set out in the Company's Notice of Meeting and Information Circular, dated November 8th, 2024, were approved by the requisite majority of votes cast at the Meeting with 23.53% of shareholder proxies returned.Details of the resolutions are provided below as well as an update that was presented to shareholders at the Meeting.This announcement has been authorised for release by the Board of Kincora Copper Limited.By order of the Board of Directors:Cameron McRae, Chairmanenquiries@kincoracopper.com or +1 604 283 1722Kincora Copper Limited (ARBN 645 457 763)Executive office CanadaSubsidiary office Australia 400 - 837 West Hastings StreetVista AustraliaVancouver, BC V6C 3N6, CanadaLevel 4, 100 Albert RoadTel: 1.604.283.1722South Melbourne, Victoria 3205Fax: 1.888.241.5996Tel: +613 9692 7222 Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) or the Australian Securities Exchange accepts responsibility for the adequacy or accuracy of this release.AGM detailsAudited Annual Report Shareholders received and considered the Financial Statements for the financial year ended December 31, 2023 and the report of the auditor thereon.Number of Directors | 99.89% ForShareholders approved retaining the number of directors at five (5).Election of Directors Shareholders voted in favour of Kincora's management's nominees to the board of directors: Jonathan (Sam) Spring (99.87% For), John Holliday (99.87% For), Luke Murray (99.81% For), Cameron McRae (91.71% For) and Jeremy Robinson (99.85% For).Auditor Appointed | 100.00% ForManning Elliot LLP was appointed Auditor of the Company to hold office until the next AGM or until its successor is duly appointed, and the directors were authorized to fix the Auditor's remuneration.Approval of Issue of Tranche 2 Placement Shares | 98.83% ForShareholders passed an ordinary resolution to ratify the issuance prior placement shares as described in the Information Circular.Approval of Issuance Placement Option | 98.75% ForShareholders passed an ordinary resolution to ratify the issuance of placement options relating to prior placement shares as described in the Information Circular.Ratification of Prior Issuance of Placement Shares | 99.58% ForShareholders passed an ordinary resolution to ratify the issuance prior placement shares as described in the Information Circular.Share Capacity | 99.50% ForShareholders passed a special resolution re-approving the capacity to issuance up to an additional 10% capital over a 12 month period pursuant to ASX Listing Rule 7.1A as described in the Information Circular.Equity Incentive Plan (EIP) | 99.74% ForShareholders passed an ordinary resolution re-approving of the existing EIP as amended as described in the Information Circular.Shares for Services Agreement | 90.76% ForShareholders passed an ordinary resolution re-approving of the existing shares for services agreements as described in the Information Circular.Ratification of Prior Issuance of Options pursuit to EIP | 90.84% ForShareholders passed an ordinary resolution to ratify the issuance prior options pursuit to the existing EIP as described in the Information Circular.To view the source version of this press release, please visit https://www.newsfilecorp.com/release/233137 Copyright 2024 ACN Newswire via SeaPRwire.com.
More